Our innovative women’s health products were featured in Chain Drug Review newsletter earlier this year. Chain Drug Review is a trade publication that covers all the latest and greatest in retail pharmacy news and innovations. FemiClear herpes and vaginal health products are now available in pharmacies all over the country, so we’re proud this important trade publication has recognized us as a category leader.
Here’s the excerpt about OrganiCare and FemiClear products, complete with some great quotes from our founder and CEO, Caroline Goodner:
Feminine care sales rise across array of segments
A range of feminine care categories performed strongly in the 12 weeks ended December 26, as angst over the pandemic’s persistence took a toll on women’s well-being. Growing segments in drugstores included vaginal treatments, which saw sales rise 6.1% to $33.8 million, and all other feminine hygiene/medical treatments, which were up 6.2% to $20.4 million. Products for routine hygiene also benefited from women’s increased attention to their needs, with sanitary napkins/liners posting 14.6% growth and tampons up 11.4%.
“At First Quality, we approach feminine care holistically, taking into consideration life stage and lifestyle," says Sima Delafraz, the company’s executive global leader of sales and marketing. “It’s why we launched Incognito by Prevail, a line of 3-in-1 feminine pads with multi-fluid technology to provide protection against multiple kinds of leaks. ”For many women, bladder leaks start happening in their 30s and 40s, with pregnancy and childbirth possibly triggering the changes, notes Delafraz. At the same time, they still need period protection and products for daily freshness. Incognito liners and pads deliver 3-in-1 performance for women “when they need it and how they need it, whatever the day might bring.” They also come with access to Prevail eNurses, available 24/7 to confidentially answer questions and help women select the right products to fit their needs.
Two years into the pandemic, health and wellness remain top of mind for consumers, and more retailers are investing in this space, she adds. “We see wellness extending beyond the individual; it’s also about what’s good for the planet. In the feminine care category, there is growing consumer interest in products that are sustainably made using natural materials.
Consumers are also becoming more aware of the importance of skin-friendly materials.” A recent Mintel report showed that in the U.S. 36% of users look for sanitary pads that are made with breathable materials. First Quality sees the demand for sustainable, skin-friendly feminine care products continuing to grow over the next few years. The company’s health care background and deep consumer insights can help retailers develop more robust strategies for the feminine care category. “We know that the products we make are personal and have a significant impact on women’s daily lives,” Delafraz says. “Taking a personalized approach to all ages and stages of feminine care will be key for retailers to win in the category, because women look at their intimate care holistically. They want products that not only perform and protect, but evolve with them throughout their lives while providing better care for themselves and the environment.”
The ongoing COVID-19 pandemic continues to be a source of significant stress and anxiety for women.
The social, cultural and individual changes of the past two years (everything from illness and increased caregiving responsibilities to employment and childcare instability) have taken a toll on women’s overall health and well-being. Research indicates that higher levels of stress can lead to an increase of genital herpes out-breaks, especially for women.
OrganiCare has seen this correlate to the rise in sales of its all-natural herpes relief product, FemiClear, in 2020 and 2021.Caroline Goodner, the company’s chief executive officer, says, “I am gratified to be able to help people minimize their outbreaks, which can be physically painful and emotionally triggering. The pandemic has been difficult for everyone, and this is one less stressor they have to deal with.”
Retail partners have jumped to offer OrganiCare products, she notes. CVS Pharmacy (an early adopter) carries FemiClear in the sexual wellness and feminine hygiene aisles. Walgreens and Rite Aid have both added OrganiCare’s herpes and vaginal itch products to their feminine and sexual health lineups.
“We’ve found most consumers are looking for our products alongside sexual and feminine products." CVS added two SKUs for genital herpes symptoms in a prime location near products like condoms and Plan B. “We have learned this is a commonplace consumers would think to find a product for herpes.” says Goodner. “CVS is a great partner.”
COVID has taken a toll on women's overall health.
Walgreens continues to add regiment items like FemiClear Itch Relief. It added the FemiClear for Genital Herpes Mutli-Symptom item in the feminine hygiene area to create a one-stop shop for women's vaginal health. Rite Aid added several items at once in the feminine hygiene area to ensure consumers can treat a multitude of vaginal health issues including yeast infections, genital herpes outbreaks and vaginal itch.
FemiClear ointment kills more than 99.9% of HSV-1 and HSV-2*,the two herpes viruses, Goodner says, and over 90% of users reported less pain, burning and itching. Over 80% reported a shorter duration outbreak, and more than half reported no blister formed when used at the first tingle.
This year, OrganiCare aims to become a trusted online re-source to provide education and support on genital herpes, feminine and sexual health, and overall well-being. FemiClear will partner with experts in the space, like Herpes Could Never and Dr. Jessica Shepherd, to support those who identify as women “as they navigate through their symptoms and emotional journey,” says Goodner.
FemiClear products are making a difference in the lives of women—and people are taking notice! Check out our full line of natural and non-toxic products specially-formulated for your healthiest V.
*Independent laboratory test measured the antiviral activity of FemiClear using a suspension time-kill procedure against herpes simplex I & II. Not a cure for herpes or a replacement for prescription antiviral medication.
**As self-reported in a comprehensive IRB approved study of >50 women diagnosed and actively experiencing a genital herpes outbreak. These women received modest compensation. Not a cure for herpes or a replacement for prescription antiviral medication. Individual results may vary. Data on file, contact FemiClear.